VERGARO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 698
EU - Europa 426
AS - Asia 110
AF - Africa 1
SA - Sud America 1
Totale 1.236
Nazione #
US - Stati Uniti d'America 698
RU - Federazione Russa 230
IT - Italia 88
IE - Irlanda 56
HK - Hong Kong 36
SG - Singapore 30
SE - Svezia 27
CN - Cina 20
IN - India 16
FI - Finlandia 11
JO - Giordania 6
ES - Italia 4
DE - Germania 3
FR - Francia 2
GB - Regno Unito 2
JP - Giappone 2
BR - Brasile 1
CI - Costa d'Avorio 1
DK - Danimarca 1
NO - Norvegia 1
UA - Ucraina 1
Totale 1.236
Città #
Santa Clara 163
Fairfield 85
Ashburn 65
Dublin 56
Seattle 45
Woodbridge 40
Cambridge 31
Houston 31
Singapore 28
Hong Kong 26
Wilmington 26
Chandler 22
Moscow 17
Lawrence 13
Rome 13
Altamura 12
Florence 11
Ann Arbor 10
Princeton 10
San Diego 9
Mumbai 8
Renton 7
Shanghai 7
Helsinki 6
Medford 6
West Jordan 6
Beijing 5
Pisa 5
Pune 5
Ciudad Rodrigo 4
Massa 4
New York 4
Boston 3
Buffalo 3
Chennai 3
Falls Church 3
Hillsboro 3
Yubileyny 3
Boardman 2
Boydton 2
Catanzaro 2
Cerreto Guidi 2
Genoa 2
Kent 2
Lappeenranta 2
Livorno 2
Los Angeles 2
Milan 2
Naples 2
Romola 2
St Petersburg 2
Abidjan 1
Calenzano 1
Copenhagen 1
Falkenstein 1
Frankfurt am Main 1
Giarre 1
Guangzhou 1
London 1
Oslo 1
Prescot 1
Quanzhou 1
Redmond 1
Redwood City 1
Stockholm 1
São Paulo 1
Wuhan 1
Totale 840
Nome #
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis 149
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: How useful, how feasible? 127
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 110
Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging 107
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 101
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 95
Treatment of cardiac transthyretin amyloidosis: an update 89
Sex-related differences in chronic heart failure 88
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 79
Clinical pathway for cardiomyopathies: A genetic testing strategy proposed by ANMCO in Tuscany 61
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 60
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 51
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 50
Concordant Versus Discordant Left Bundle Branch Block in Heart Failure Patients: Novel Clinical Value of an Old Electrocardiographic Diagnosis 47
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 44
Totale 1.258
Categoria #
all - tutte 4.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 15 21 19 19 21 10 11 3
2020/202191 3 6 3 4 17 3 4 5 15 19 11 1
2021/202263 2 0 13 1 0 4 1 4 3 11 7 17
2022/2023188 11 37 12 5 13 30 42 13 16 0 6 3
2023/2024180 2 13 16 8 19 21 8 34 9 20 13 17
2024/2025489 24 90 51 126 198 0 0 0 0 0 0 0
Totale 1.258